Shah Gaurav

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$381,513.00
Insider Sells Quantity
9
Insider Sells Sum
$3.97M

Insider Activity of Shah Gaurav

According to the SEC Form 4 filings, Shah Gaurav, being in a position of

  1. CEO at Rocket Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 39712 shares for $1.01M,
    over all time since 2019-03-01, has bought 22000 shares for $381,513, and sold 210595 shares for $3.97M.

The largest purchase of all time was on 2022-02-07 and amounted to 22000 shares of Rocket Pharmaceuticals, Inc. for $381,513.

The largest sale of all time was on 2019-03-04 and amounted to 49800 shares of Rocket Pharmaceuticals, Inc. for $860,544.

Biography of Shah Gaurav

No biography is available at this moment.

2024-08-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,650
0.0105%
$18.50$178,5640%
2024-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,790
0.0108%
$23.35$228,597-15.43%
2024-02-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
20,272
0.0224%
$29.84$604,876-24.93%
2023-08-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,767
0.006%
$15.47$73,750+51.21%
2023-05-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,122
0.0051%
$21.38$88,108+4.87%
2023-02-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
12,194
0.015%
$19.06$232,418+2.41%
2022-02-07PurchaseRocket Pharmaceuticals, Inc.
RCKT
CEO
22,000
0.0339%
$17.34$381,513-6.75%
2019-03-05SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
50,000
0.1136%
$16.90$845,000+0.61%
2019-03-04SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
49,800
0.1083%
$17.28$860,544-6.3%
2019-03-01SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
50,000
0.1087%
$17.12$856,000-5.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.